Results 131 to 140 of about 24,950 (282)
Purpose: Benign prostate hyperplasia (BPH) is a common age-related chronic condition. Its pathogenesis involves androgen imbalance, inflammation, oxidative stress, and endoplasmic reticulum (ER) stress.
Geum-Hwa Lee +7 more
doaj +1 more source
PurposeNumerous prior analyses have highlighted a potential link between androgen suppression therapy (AST) and bladder cancer (BCa). However, there is a notable gap in research specifically examining the influence of finasteride on BCa risk and clinical
Ailing Yu +27 more
doaj +1 more source
Guidelines on the use of finasteride in androgenetic alopecia
Venkataram Mysore, BM Shashikumar
openalex +1 more source
A randomized, double blind, placebo-controlled study (placebo and Finasteride 1 or 5 mg/die) was carried out in 34 patients with benign prostatic hyperplasia (BPH). After 12 months of treatment all patients received Finasteride 5 mg/die. Follow-up ranges
Miano L +3 more
core
RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF FINASTERIDE AND TAMSULOSIN IN TABLET FORMULATIONS
Ashu Mittal +4 more
openalex +2 more sources
The Steroidogenesis Inhibitor Finasteride Reduces the Response to Both Stressful and Rewarding Stimuli [PDF]
Sean C. Godar +11 more
openalex +1 more source
THU372 Finasteride Induced Hyperglycemia [PDF]
Vivek Bose, Dorothy Santos Martinez
openalex +1 more source
Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women
Rui Oliveira Soares +3 more
openalex +2 more sources
5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss [PDF]
JH Yeon +6 more
openalex +1 more source

